Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.24.1.1.u2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Schedule of financial instruments required to be measure at fair value on recurring basis

 

 

March 31, 2024

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Marketable securities – trading securities

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper

 

$ -

 

 

$ 3,439

 

 

$ -

 

 

$ 3,439

 

Asset-backed securities

 

 

-

 

 

 

985

 

 

 

-

 

 

 

985

 

Corporate debt

 

 

-

 

 

 

1,490

 

 

 

-

 

 

 

1,490

 

US Government

 

 

-

 

 

 

500

 

 

 

-

 

 

 

500

 

 

 

$ -

 

 

$ 6,414

 

 

$ -

 

 

$ 6,414

 

 

 

 

December 31, 2023

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Marketable securities – trading securities

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper

 

$ -

 

 

$ 4,654

 

 

$ -

 

 

$ 4,654

 

Asset-backed securities

 

 

-

 

 

 

974

 

 

 

-

 

 

 

974

 

Corporate debt

 

 

-

 

 

 

1,482

 

 

 

-

 

 

 

1,482

 

US Government

 

 

-

 

 

 

501

 

 

 

-

 

 

 

501

 

 

 

$ -

 

 

$ 7,611

 

 

$ -

 

 

$ 7,611

 

Schedule of antidilutive securities excluded from the computation of earnings

 

 

March 31,

 

 

March 31,

 

 

 

2024

 

 

2023

 

Stock options

 

 

763,105

 

 

 

508,605

 

Warrants

 

 

239,357

 

 

 

259,155

 

 

 

 

1,002,462

 

 

 

767,760